July 31, 2017 09:25 AM EDT
R&D

In­Vi­vo Ther­a­peu­tics shares tank af­ter a third pa­tient death in lead study

Arsalan Arif

Founder

Shares of In­Vi­vo Ther­a­peu­tics $NVIV tanked this morn­ing af­ter the Cam­bridge, MA-based biotech said it halt­ed en­roll­ment in its lead IN­SPIRE study af­ter the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Up­dat­ed: CEO of Unit­ed­Health in­sur­ance unit shot and killed in New York in what po­lice call ‘a brazen, tar­get­ed ...

Lil­ly beats No­vo in bell­wether head-to-head weight loss study

As 23andMe strug­gles, an­oth­er ge­net­ic test­ing com­pa­ny bets on drug dis­cov­ery

GSK makes an­oth­er ADC deal, this time with BioN­Tech's part­ner Du­al­i­ty­Bio

Lil­ly drops body mass ranges from FDA la­bel for weight loss drug

On heels of Mar­i­Tide da­ta, Dan­ish obe­si­ty biotech dis­clos­es €80M Se­ries A

A service from the Financial Times